| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.0035 | 1 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.0048 | 1 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |